Literature DB >> 22700527

Timing of aneurysm treatment after subarachnoid hemorrhage: relationship with delayed cerebral ischemia and poor outcome.

Sanne M Dorhout Mees1, Andrew J Molyneux, Richard S Kerr, Ale Algra, Gabriel J E Rinkel.   

Abstract

BACKGROUND AND
PURPOSE: The ideal timing of coiling or clipping after aneurysmal subarachnoid hemorrhage is unknown. Within the International Subarachnoid Aneurysm Trial we assessed differences in incidence of delayed cerebral ischemia and clinical outcome between different timings of treatment.
METHODS: The treated 2106 patients randomized to coiling or clipping were divided into 4 categories: treatment <2 days, on days 3 to 4, on days 5 to 10, and >10 days after the hemorrhage. ORs with 95% CI were calculated with logistic regression analysis for delayed cerebral ischemia, poor outcome at 2 months, and 1 year for the different timing categories, with treatment <2 days as reference. Analyses were performed for all patients, and for coiled and clipped patients separately, and were adjusted for baseline characteristics.
RESULTS: Adjusted ORs of delayed cerebral ischemia for treatment on days 5 to 10 were 1.18 (95% CI, 0.91-1.53) for all patients, 1.68 (95% CI, 1.17-2.43) after coiling, and 0.79 (95% CI, 0.54-1.16) after clipping. ORs for poor outcome at 2 months were 1.16 (95% CI, 0.89-1.50) for treatment (clipping and coiling combined) at 3 to 4 days, 1.39 (95% CI, 1.08-1.80) for treatment at 5 to 10 days, and 1.84 (95% CI, 1.36-2.51) for treatment >10 days. ORs for coiled and clipped patients separately were in the same range. Results for outcome at 1 year were similar.
CONCLUSIONS: Our results support the current practice for early aneurysm treatment in subarachnoid hemorrhage patients. The risk for poor outcome was highest when treatment was performed after day 10; postponing treatment in patients who are eligible for treatment between days 5 to 10 after subarachnoid hemorrhage is not recommended.

Entities:  

Mesh:

Year:  2012        PMID: 22700527     DOI: 10.1161/STROKEAHA.111.639690

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  14 in total

Review 1.  Early endovascular treatment of subarachnoid hemorrhage.

Authors:  Jordi A Matias-Guiu; Carmen Serna-Candel
Journal:  Interv Neurol       Date:  2013-03

2.  Initial experience in the microsurgical treatment of ruptured brain aneurysms in the endovascular era: characteristics and safety of the learning curve in the first 300 consecutively treated patients.

Authors:  Eduardo Vieira; Thiago C Guimarães; Erton C A Pontes; Ana C V Silva; Marcelle C Carneiro; Arlindo U Netto; Lívio Pereira; Auricélio B Cezar; Igor Faquini; Nivaldo S Almeida; Maria F L Griz; Hildo R C Azevedo-Filho
Journal:  Acta Neurochir (Wien)       Date:  2022-03-03       Impact factor: 2.216

Review 3.  Aneurysmal Subarachnoid Hemorrhage: Review of the Pathophysiology and Management Strategies.

Authors:  Marcey L Osgood
Journal:  Curr Neurol Neurosci Rep       Date:  2021-07-26       Impact factor: 5.081

4.  Treatment at Safety-Net Hospitals Is Associated with Delays in Coil Embolization in Patients with Subarachnoid Hemorrhage.

Authors:  Daniel A Donoho; Arati Patel; Ian A Buchanan; Frances Chow; Li Ding; Arun P Amar; Frank Attenello; William J Mack
Journal:  World Neurosurg       Date:  2018-09-08       Impact factor: 2.104

5.  The Factors Associated with Outcomes in Surgically Managed Ruptured Cerebral Aneurysm.

Authors:  Lai Chuang Chee; Johari Adnan Siregar; Abdul Rahman Izani Ghani; Zamzuri Idris; Noor Azman A Rahman Mohd
Journal:  Malays J Med Sci       Date:  2018-02-28

6.  Timing of treatment of aneurysmal subarachnoid haemorrhage: are the goals set in international guidelines achievable?

Authors:  Abdurehman Choudhry; Daniel Murray; Paula Corr; Deirdre Nolan; Deirdre Coffey; Stephen MacNally; Alan O'Hare; Sarah Power; Matthew Crockett; John Thornton; Daniel Rawluk; Paul Brennan; Mohsen Javadpour
Journal:  Ir J Med Sci       Date:  2021-02-18       Impact factor: 1.568

7.  Interleukin-6 as a Prognostic Biomarker in Ruptured Intracranial Aneurysms.

Authors:  Hung-Wen Kao; Kwo-Whei Lee; Chen-Ling Kuo; Ching-Shan Huang; Wan-Min Tseng; Chin-San Liu; Ching-Po Lin
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

8.  Use of a Diagnostic Score to Prioritize Computed Tomographic (CT) Imaging for Patients Suspected of Ischemic Stroke Who May Benefit from Thrombolytic Therapy.

Authors:  Wen Yea Hwong; Michiel L Bots; Sharmini Selvarajah; L Jaap Kappelle; Zariah Abdul Aziz; Norsima Nazifah Sidek; Ilonca Vaartjes
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

9.  Benefits of early aneurysm surgery: Southern Iran experience.

Authors:  Abdolkarim Rahmanian; Mohammad Jamali; Ali Razmkon; Juri Kivelev; Rossana Romani; Ehsan-Ali Alibai; Juha Hernesniemi
Journal:  Surg Neurol Int       Date:  2012-12-26

10.  Cyclophilin A in Ruptured Intracranial Aneurysm: A Prognostic Biomarker.

Authors:  Hung-Wen Kao; Kwo-Whei Lee; Wei-Liang Chen; Chen-Ling Kuo; Ching-Shan Huang; Wan-Min Tseng; Chin-San Liu; Ching-Po Lin
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.